Eris Lifesciences partnership with Natco Pharma for Semaglutide launch in India
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus
The surge has been driven largely by COCO stores, with 755 COCO and 165 FOFO outlets added this fiscal year
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
Subscribe To Our Newsletter & Stay Updated